US Radiotherapy Market Analysis Report 2022 to 2030

US Radiotherapy Market Analysis

$ 3999

The US radiotherapy market is projected to grow from $2.9 Bn in 2022 to $3.97 Bn by 2030, registering a CAGR of 4% during the forecast period of 2022-30. The market is primarily driven by factors such as increasing cancer prevalence, rising demand for non-invasive cancer treatments, and technological advancements in radiotherapy equipment. The US is one of the largest markets for radiotherapy globally, with a significant number of cancer treatment centers and a high level of investment in research and development. The key players in the US radiotherapy market include major medical device manufacturers and radiation therapy providers such as Varian Medical Systems, Elekta AB, Accuray Incorporated, and Siemens Healthineers.

ID: IN10USPH043 CATEGORY: Pharmaceuticals GEOGRAPHY: US AUTHOR: Shivam Zalke

Buy Now

US Radiotherapy Market Executive Summary

A CAGR of 4% is anticipated for the forecast period of 2022-30, with the US radiotherapy market increasing from $2.9 billion in 2022 to $3.97 billion by 2030.

In the US radiotherapy market, radiation is used to treat conditions like cancer and other illnesses. The market is expanding quickly as a result of improvements in radiotherapy technology and the rising incidence of cancer. One of the most popular cancer treatments, radiotherapy reduces tumours, stops cancer from returning, and relieves uncomfortable symptoms.

The market is primarily driven by variables like rising rates of cancer, rising demand for non-invasive cancer treatments, and technological developments in radiotherapy equipment. With a sizable number of cancer treatment facilities and significant investment in R&D, the US is one of the largest markets for radiotherapy in the world.

A variety of radiotherapy technologies, such as systemic radiation therapy, internal radiation therapy (brachytherapy), and external beam radiation therapy, are available on the market. Proton therapy, stereotactic body radiation therapy, and intensity-modulated radiation therapy are the three most popular kinds of external beam radiation therapy. These procedures employ high-energy radiation to kill cancer cells while causing the least amount of harm to the surrounding healthy tissue.

Major radiation therapy companies and medical device manufacturers like Varian Medical Systems, Elekta AB, Accuray Inc., and Siemens Healthineers are among the key players in the US radiotherapy market. These businesses develop, produce, and market a variety of radiotherapy tools and technologies in addition to offering training, assistance, and other services to medical professionals.

The US radiotherapy market is, in general, a dynamic and quickly developing market that is being driven by technological advancements, rising cancer prevalence, and rising demand for minimally invasive cancer treatments. In the upcoming years, the market is anticipated to expand as new radiotherapy technologies are created and the demand for cancer treatment rises.

us radiotherapy market analysis

Market Dynamics

Growth Drivers

The advantages of radiation treatments have motivated several activities, including conferences and symposia, in recent years. In such gatherings, a bigger focus is placed on raising awareness of the advantages and therapeutic benefits that radiation provides for a variety of malignancies. For instance, Portugal will host the 6th Cancer International Congress in September 2022. The sixth Cancer World Congress will focus on "Personalized Cancer Diagnosis and Treatment" in 2022. In May 2022, the fifth Global Cancer Summit (GCS-2022) took place. Under the topic "Living with cancer in the 21st century," BioGenesis Health Cluster, Bangalore, and World Cancer Foundation virtually organised the event.

To raise awareness and provide radiographers and oncologists with training for radiation operations, a number of radiotherapy-related events are being planned. Such activities are crucial in spreading knowledge about the advantages of the various radiation techniques, which are anticipated to increase demand for and uptake of radiotherapy equipment.

Competitive Landscape

Key Players

There are several key players in the US radiotherapy market, including:

Varian Medical Systems
Elekta AB
Accuray Incorporated
Siemens Healthineers
ViewRay Incorporated

Overall, through the creation of new products and technologies, these businesses are promoting innovation and growth in the US radiotherapy market.

Healthcare Policies and Regulatory Landscape

The US radiotherapy market is subject to a range of healthcare policies and regulatory requirements, including:

FDA regulations: Radiotherapy equipment and software must be approved by the US Food and Drug Administration (FDA) before they can be marketed and sold in the US. The FDA reviews clinical trial data and other information to determine the safety and effectiveness of these products.
Medicare reimbursement: Radiation treatments are frequently funded by Medicare, the US government-run health insurance programme for adults over 65 and persons with certain impairments. Medicare sets reimbursement rates for different types of radiotherapy treatments, which can impact the profitability of radiotherapy providers.
laws at the state level: State laws may also have an influence on the radiation industry, especially in regard to medical professional licencing standards and the development and management of radiotherapy facilities.
Guidelines from the National Comprehensive Cancer Network (NCCN): The NCCN is an alliance of 28 leading cancer centres in the US, which develops guidelines for the diagnosis and treatment of various types of cancer. These recommendations can affect the use of radiotherapy treatments and are frequently used by healthcare professionals to guide treatment choices.
Health insurance policies: Health insurance policies may affect the usage and availability of radiation treatments, as well as the cost burden on patients. Some health insurance policies may limit the types of radiotherapy treatments that are covered or require higher out-of-pocket costs for certain treatments.

Overall, these laws and rules may have an effect on how radiotherapy goods and services are developed, used, and profitable in the US market.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

US Radiotherapy Market Segmentation

By Type (Revenue, USD Billion):

External Beam Radiation Therapy
Linear Accelerators
Compact Advanced Radiotherapy Systems
Cyberknife
Gamma Knife
Tomotherapy
Proton Therapy
Cyclotron
Synchrotron
Internal Beam Radiation Therapy
Brachytherapy
Seeds
Applicators and Afterloaders
Electronic Brachytherapy
Systemic Radiation Therapy
Others

By Technology (Revenue, USD Billion):

External Beam Radiotherapy
Intensity-Modulated Radiation Therapy (IMRT)
Image-Guided Radiation Therapy (IGRT)
Stereotactic Radiation Therapy (SRT)
3D Conformal Radiation Therapy (3D-CRT)
Particle Therapy
Internal Beam Radiotherapy
Brachytherapy
High-Dose Rate Brachytherapy
Low-Dose Rate Brachytherapy
Image-Guided Brachytherapy
Pulse-Dose Rate Brachytherapy
Systemic Radiation Therapy
Intravenous Radiotherapy
Oral Radiotherapy

By Application (Revenue, USD Billion):

Breast Cancer
Cervical Cancer
Colon and rectum Cancers
Stomach Cancer
Lung Cancer
Prostate Cancer
Skin Cancer
Liver Cancer
Other types of cancer

By End User (Revenue, USD Billion):

Hospitals
Radiotherapy Centers & Ambulatory Surgery Centers
Cancer Research Institutes

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.